Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon Apr 09, 2021 2:27am
135 Views
Post# 32964884

RE:RE:RE:RE:RE:RE:RE:RE:Presentation

RE:RE:RE:RE:RE:RE:RE:RE:PresentationInvestors being impatient you say? Some have been patient for many many years. Everyone has their limits especially when you see the same BS over and over again. Keep waiting and the markets will be in the dumps. Just another excuse for management like their 'different direction' excuse. I have heard that one many times too. Wonder why pharma, who is privy to NDA info, goes another direction. They all use the pouch for a couple years and go. My guess is because it didn't work for whatever they were testing it with. Or they don't like managements vision (or lack thereof). Maybe rose knows better. All those waiting for SVA to be valued as it's peers, have you checked the value of peers? We are there but not by way of price appreciation. One also has to keep in mind if the technology is as good as we think, it poses a huge threat to the global insulin suppliers. It'd be like oil companies making a deal with tesla. I've always been of the opinion that we get one of the other indications up and running and prove it works and then let the diabetes folk come running and outbidding. Phil will be bankrupt before even getting any other indications out of the gate. This should be happening in parallel with $ from pharma via joint ventures. Instead we dilute over and over and work in series not parallel. All the eggs are in one basket right now. Hope Phil doesn't drop it. We are lucky to be at 1.60 considering we have had zero news for months. Nothing but worthless presentations. You got lucky with one presentation Phil, time to flip through your playbook and try something else. Oh wait, you don't have a playbook so I guess more presentations it is. There is a thing called a news release which would enable you to give us updates on current patients. You don't have to wait for presentations.
Redbaron2211 wrote: Salley maybe I'm unrealistic it's a possibility but we had the same divergence last year before the AGM and many of the optimistic view points did manifest.  If investors are dissatisfied with management's performance they should vote but call the company and think for yourself.

I personally dont feel/think Philip is an ego freak, I hope he will get some satisfaction in proving the naysayers wrong and if it acts as a motivation that's fine.  Anyways I don't get the same impressions, possibly I'm blind to it who knows.  


<< Previous
Bullboard Posts
Next >>